BIO KART

A Rousing Entrepreneur Influencing The Entire Feminism

One such frontrunner in the industry is Biokart India, which ha made a name for itself as one of the pioneering Genomic companies with in-house processing capabilities When it comes to understanding the requirements and offering tailor-made solutions that meet the researcher’s needs, the company is one o the top service providers The company ’ s directors have been involved in Genomics-related bioinformatics from its inception and they have more than 60 papers to their name. "We have a specialized team of professionals in the field of wet lab bioinformatics and biology who collaborate to determine the bes workflo cula biologis ware develop th o expertis dres each s aste pipeline

A Robu In Place e we lab that n. In house c based devices ( ) p cture several in-house servers are used for a variety of functions including storage and data processing. As a starting point, each server has 1TB of RAM and 128 threads

Head Office

In today’s time, the genomics market in India is expanding at a breakneck pace Bioinformatics is a well-established science that includes not just genomes, but also proteomics, drug design and discovery, and so on In the recent past, there has been a major leap in the field of genomics, which has catapulted bioinformatics for sequencing analysis/statistics as well as the development of new pipelines Technological developments, increased research funding, and the presence of a large number of industry competitors and research institutes are fueling the market in India’s growth Aside from tool development, bioinformatics is essential for comprehending multi-omics research and integrating genomes, proteomics, and other data sets As a result, there is an enormous opportunity for the creation of fresh tools and approaches. However, the obstacles in this market would be bridging the gap between knowing the client’s requirement, the wet lab operations, and the desired deliverables, and leveraging the extensive tools available for getting the required outcomes. One such frontrunner in the industry is Biokart India, which has made a name for itself as one of the pioneering Genomics companies with in-house processing capabilities When it comes to understanding the requirements and offering tailor-made solutions that meet the researcher’s needs, the company is one of the top service providers The company ’ s directors have been involved in Genomics-related bioinformatics from its inception, and they have more than 60 papers to their name "We have a specialized team of professionals in the field of wet lab, bioinformatics, and biology who collaborate to determine the best workflow Biokart India’s core team consists of molecular biologists, biotech engineers, system biology experts, and software developers. All members of the core team contribute a wealth of expertise in their respective industries, which allows us to address each service and grow and develop better and faster pipelines/tools”, says Vikram

S, Founder at Biokart India

A Robust Infrastructure

In Place Biokart India has a full-fledged facility in terms of the wet lab that is required for handling and sequence data creation. Inhouse capabilities range from Sanger Sequencing to NGS-based devices (Illumina) In terms of computational infrastructure, several in-house servers are used for a variety of functions, including storage and data processing As a starting point, each server has 1TB of RAM and 128 threads

When operating in the Genomics domain of research, Sanger services is the starting point for any researcher to understand a short sequence (i e , a gene or a mutation of a definite location) It is also the most accurate methodology in identifying the microorganisms provided the sample is of a pure culture (i.e. not a mixture of microorganisms). While NGS may be seen as a progression from Sanger sequencing, which allows microbe identification even if it combines different cultures. NGS may also be used to sequence the whole genome of a small organism such as bacteria or a huge creature such as humans or plants

It is also a critical tool for studying the characteristics of gene expression using RNA sequencing technologies Sanger/NGS applications, to name a few, are laboratory processes that generate sequencing reads in the form of ATGCs- bioinformatics is the perspective that makes sense and provides answers to the researcher s queries. As the Biotech domain has grown and demand in the niche has increased, numerous new companies have sprouted, serving various sectors of the services Biokart India Pvt Ltd is a stalwart in its area and will continue to be so because of its best-in-class service delivery. The company finds its edge over its peers due to its deep-rooted understanding of the requirements of the end users. The company ’ s specialists comprehend the expectations and personalize our aid to generate the greatest results by having in-depth knowledge of accessible tools as well as coding and programming talents.

A Noteworthy Journey

In the year 2011, Biokart began operations as a distribution company By 2013, the company had developed into a service provider, and it acquired its first Sanger Sequencing equipment in 2015, followed by the NGS machine (Illumina Miseq) in 2019. Recognizing these achievements, Biokart is proud to say that it is one of the few firms to have established a complete Sanger and NGS processing facility, as well as a cutting-edge Bioinformatics facility, without raising any funding or investments The entire journey has been on an upward trend, with a significant amount of earnings being pushed back into the company to fuel the rising need for growth and infrastructure. “We are very grateful to our esteemed clients, who have been crucial in our growth in terms of recommending us to their peers and enabling us to have steady organic growth”, states Vikram. The company is currently developing Artificial Intelligence and Machine Learning technologies and merging them with existing tools to handle various pandemic-related screening and monitoring for clinical genetic diagnostics In the following year, it will also enter the field of clinical genetic diagnostics on a war footing “As a close-knit family, we at Biokart India work closely together. We look forward to developing freshmen out of college into full-fledged microbiologists and biotechnologists. We believe in discipline and work together to achieve the organization's aims and objectives”, concludes Vikram

We can confidently state that our experience with cross-platform analysis allows us to arrive at a realistic answer. We also take satisfaction in designing our own in-house pipelines that reduce processing time by more than tenfold while meeting or exceeding the gold standard tool set criteria As a result, we strive to set new benchmarks in terms of client expectations

- Vikram.

In recent years, women entrepreneurs have made significant strides in the biotech field From developing innovative technologies to launching successful startups, women have been making their mark in an industry traditionally dominated by men. One example of a successful woman entrepreneur in biotech is Mrs. Ankita Kumari majoring in the field of Biotechnology, having completed her education at Haldia Institute of Technology she brings with her the dedicated expertise and work experience of having worked in Darbhanga Medical College and Hospital, Bihar, Chittaranjan National Cancer Institute, Kolkata, and finally at Biokart India Pvt Ltd , Bangalore, where she is still a crucial part in heading the operations As a Co-Founder of Xploregen Discoveries, she has been leading the whole team with dedication and soaring new heights in the field